
MIT’s Implantable Glucagon Device
In a groundbreaking advancement for diabetes care, engineers at the Massachusetts Institute of Technology (MIT) have unveiled a 3D-printed implantable device aimed at combating hypoglycemia in individuals with Type 1 diabetes. This innovative device, roughly […]